JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamberlain, B. K.
Right arrow Articles by Fleischer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamberlain, B. K.
Right arrow Articles by Fleischer, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 259, Issue 12, 7547-7553, Jun, 1984

Inhibition of calcium-induced calcium release from purified cardiac sarcoplasmic reticulum vesicles

BK Chamberlain, P Volpe and S Fleischer

A variety of reagents (local anesthetics, phenothiazines, ruthenium red, ryanodine, dicyclohexylcarbodiimide, R 24571) inhibit Ca2+-induced Ca2+ release from purified canine cardiac sarcoplasmic reticulum (SR). Most of these compounds also increase the rate of net Ca2+ uptake by cardiac SR while moderately inhibiting Ca2+-dependent ATP hydrolysis, and together these two effects produce increased coupling ratios for ATP-dependent Ca2+ transport (Ca2+/ATP approximately equal to 2) compared to controls (Ca2+/ATP approximately equal to 1). We conclude that Ca2+ efflux normally occurs during net Ca2+ uptake by isolated cardiac SR vesicles and that this phenomenon is responsible for the low coupling ratios generally observed for cardiac SR preparations. Blockers of sarcolemmal Ca2+ channels (nitrendipine, diltiazem, methoxyverapamil, dantrolene), at concentrations much greater than those effective for sarcolemmal Ca2+ fluxes, do not affect either Ca2+ uptake or Ca2+ release by cardiac SR. Furthermore, the effects of local anesthetics and phenothiazines on Ca2+ release from cardiac SR are different from those previously reported for skeletal muscle SR. These results indicate that the Ca2+ release "channels" in cardiac SR are distinct from Ca2+ channels present in cardiac sarcolemma or in skeletal muscle SR. The common hydrophobic nature but structural dissimilarity of various inhibitors of Ca2+ release from cardiac SR suggest that in some cases a hydrophobic interaction with the membrane might be involved in blocking Ca2+ efflux. On the other hand, half- maximal inhibition by 80 nM ruthenium red is suggestive of a specific ionic interaction with some component of the Ca2+ efflux pathway.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Zhang, G. G. Rodney, and M. F. Schneider
Effects of Azumolene on Ca2+ Sparks in Skeletal Muscle Fibers
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 94 - 102.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. Santra, T. K. Beuria, A. Banerjee, and D. Panda
Ruthenium Red-induced Bundling of Bacterial Cell Division Protein, FtsZ
J. Biol. Chem., June 18, 2004; 279(25): 25959 - 25965.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. G. Tsushima, J. E. Kelly, and J. A. Wasserstrom
Subconductance Activity Induced by Quinidine and Quinidinium in Purified Cardiac Sarcoplasmic Reticulum Calcium Release Channels
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 729 - 737.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
J. Jacobson and M. R. Duchen
Mitochondrial oxidative stress and cell death in astrocytes -- requirement for stored Ca2+ and sustained opening of the permeability transition pore
J. Cell Sci., March 15, 2002; 115(6): 1175 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Logan-Smith, P. J. Lockyer, J. M. East, and A. G. Lee
Curcumin, a Molecule That Inhibits the Ca2+-ATPase of Sarcoplasmic Reticulum but Increases the Rate of Accumulation of Ca2+
J. Biol. Chem., December 7, 2001; 276(50): 46905 - 46911.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Xu, A. Tripathy, D. A. Pasek, and G. Meissner
Ruthenium Red Modifies the Cardiac and Skeletal Muscle Ca2+ Release Channels (Ryanodine Receptors) by Multiple Mechanisms
J. Biol. Chem., November 12, 1999; 274(46): 32680 - 32691.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Matlib, Z. Zhou, S. Knight, S. Ahmed, K. M. Choi, J. Krause-Bauer, R. Phillips, R. Altschuld, Y. Katsube, N. Sperelakis, et al.
Oxygen-bridged Dinuclear Ruthenium Amine Complex Specifically Inhibits Ca2+ Uptake into Mitochondria in Vitro and in Situ in Single Cardiac Myocytes
J. Biol. Chem., April 24, 1998; 273(17): 10223 - 10231.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1984 by the American Society for Biochemistry and Molecular Biology.